DYNAMIC-III

The aim of this study is to compare treatment informed by ctDNA results to standard care in patients with stage III colon cancer.

Enquire

Trial overview

Topic

Bowel cancer

Description

Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colon Cancer: A Multicentre Phase II/III Randomised Controlled Study (DYNAMIC-III).

Eligibility criteria

Stage III Colon Cancer.

Study details

The study aims to investigate if taking serial blood samples monitoring for tumour cells can improve treatment for patients curatively treated for colon cancer.

Further information

For more information regarding this clinical trial click here.

Location

North Shore

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.

First name *

Last name *

Email *

Phone *

State *

Postcode *

What is the reason for enquiry?

How would you prefer to be contacted? *

Phone

By submitting you acknowledge we will use the information you are providing to contact you about your enquiry. For more information about how we handle your personal information, please refer to the GenesisCare Privacy Policy.

DYNAMIC-III

Trial overview

Thank you for submitting.

An unexpected error has occurred.

How can we help?

GenesisCare

Website policies

Contact us

Media & Social